FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065713235> ?p ?o ?g. }

• W2065713235 endingPage "104" @default.
• W2065713235 startingPage "97" @default.
• W2065713235 abstract "One of the clinical features of cystic fibrosis (CF) is a deep inflammatory process, which is characterized by production and release of cytokines and chemokines, among which interleukin 8 (IL-8) represents one of the most important. Accordingly, there is a growing interest in developing therapies against CF to reduce the excessive inflammatory response in the airways of CF patients. Since transcription factor NF-kappaB plays a critical role in IL-8 expression, the transcription factor decoy (TFD) strategy might be of interest. In order to demonstrate that TFD against NF-kappaB interferes with the NF-kappaB pathway we proved, by chromatin immunoprecipitation (ChIP) that treatment with TFD oligodeoxyribonucleotides of cystic fibrosis IB3–1 cells infected with Pseudomonas aeruginosa leads to a decrease occupancy of the Il-8 gene promoter by NF-kappaB factors. In order to develop more stable therapeutic molecules, peptide nucleic acids (PNAs) based agents were considered. In this respect PNA-DNA-PNA (PDP) chimeras are molecules of great interest from several points of view: (1) they can be complexed with liposomes and microspheres; (2) they are resistant to DNases, serum and cytoplasmic extracts; (3) they are potent decoy molecules. By using electrophoretic mobility shift assay and RT-PCR analysis we have demonstrated that (1) the effects of PDP/PDP NF-kappaB decoy chimera on accumulation of pro-inflammatory mRNAs in P.aeruginosa infected IB3–1 cells reproduce that of decoy oligonucleotides; in particular (2) the PDP/PDP chimera is a strong inhibitor of IL-8 gene expression; (3) the effect of PDP/PDP chimeras, unlike those of ODN-based decoys, are observed even in the absence of protection with lipofectamine. These informations are of great impact, in our opinion, for the development of stable molecules to be used in non-viral gene therapy of cystic fibrosis." @default.
• W2065713235 created "2016-06-24" @default.
• W2065713235 creator A5004918425 @default.
• W2065713235 creator A5010261777 @default.
• W2065713235 creator A5016208813 @default.
• W2065713235 creator A5021123711 @default.
• W2065713235 creator A5030568464 @default.
• W2065713235 creator A5037914702 @default.
• W2065713235 creator A5040500337 @default.
• W2065713235 creator A5042760242 @default.
• W2065713235 creator A5057667251 @default.
• W2065713235 creator A5076501930 @default.
• W2065713235 creator A5076841133 @default.
• W2065713235 date "2012-04-01" @default.
• W2065713235 modified "2023-09-27" @default.
• W2065713235 title "Effects of decoy molecules targeting NF-kappaB transcription factors in Cystic fibrosis IB3–1 cells" @default.
• W2065713235 cites W1627908036 @default.
• W2065713235 cites W1967279039 @default.
• W2065713235 cites W1969273529 @default.
• W2065713235 cites W1980550512 @default.
• W2065713235 cites W1989169142 @default.
• W2065713235 cites W1997096397 @default.
• W2065713235 cites W1998195903 @default.
• W2065713235 cites W2006998980 @default.
• W2065713235 cites W2008664082 @default.
• W2065713235 cites W2017177379 @default.
• W2065713235 cites W2019818589 @default.
• W2065713235 cites W2041448192 @default.
• W2065713235 cites W2042730384 @default.
• W2065713235 cites W2064376110 @default.
• W2065713235 cites W2072725805 @default.
• W2065713235 cites W2074127035 @default.
• W2065713235 cites W2076258083 @default.
• W2065713235 cites W2104213395 @default.
• W2065713235 cites W2109454767 @default.
• W2065713235 cites W2114053081 @default.
• W2065713235 cites W2117510195 @default.
• W2065713235 cites W2125713628 @default.
• W2065713235 cites W2130649423 @default.
• W2065713235 cites W2130874549 @default.
• W2065713235 cites W2136514450 @default.
• W2065713235 cites W2140166099 @default.
• W2065713235 cites W2142840964 @default.
• W2065713235 cites W2151841284 @default.
• W2065713235 cites W2154765631 @default.
• W2065713235 cites W2156982347 @default.
• W2065713235 cites W2157935494 @default.
• W2065713235 cites W2326565254 @default.
• W2065713235 cites W2415319234 @default.
• W2065713235 cites W2418751466 @default.
• W2065713235 cites W4231787971 @default.
• W2065713235 doi "https://doi.org/10.4161/adna.21061" @default.
• W2065713235 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3429536" @default.
• W2065713235 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22772035" @default.
• W2065713235 hasPublicationYear "2012" @default.
• W2065713235 type Work @default.
• W2065713235 sameAs 2065713235 @default.
• W2065713235 citedByCount "24" @default.
• W2065713235 countsByYear W20657132352013 @default.
• W2065713235 countsByYear W20657132352014 @default.
• W2065713235 countsByYear W20657132352015 @default.
• W2065713235 countsByYear W20657132352016 @default.
• W2065713235 countsByYear W20657132352017 @default.
• W2065713235 countsByYear W20657132352018 @default.
• W2065713235 countsByYear W20657132352020 @default.
• W2065713235 countsByYear W20657132352021 @default.
• W2065713235 countsByYear W20657132352022 @default.
• W2065713235 crossrefType "journal-article" @default.
• W2065713235 hasAuthorship W2065713235A5004918425 @default.
• W2065713235 hasAuthorship W2065713235A5010261777 @default.
• W2065713235 hasAuthorship W2065713235A5016208813 @default.
• W2065713235 hasAuthorship W2065713235A5021123711 @default.
• W2065713235 hasAuthorship W2065713235A5030568464 @default.
• W2065713235 hasAuthorship W2065713235A5037914702 @default.
• W2065713235 hasAuthorship W2065713235A5040500337 @default.
• W2065713235 hasAuthorship W2065713235A5042760242 @default.
• W2065713235 hasAuthorship W2065713235A5057667251 @default.
• W2065713235 hasAuthorship W2065713235A5076501930 @default.
• W2065713235 hasAuthorship W2065713235A5076841133 @default.
• W2065713235 hasBestOaLocation W20657132351 @default.
• W2065713235 hasConcept C101762097 @default.
• W2065713235 hasConcept C104317684 @default.
• W2065713235 hasConcept C129312508 @default.
• W2065713235 hasConcept C13373296 @default.
• W2065713235 hasConcept C134320426 @default.
• W2065713235 hasConcept C150194340 @default.
• W2065713235 hasConcept C153911025 @default.
• W2065713235 hasConcept C164027704 @default.
• W2065713235 hasConcept C170493617 @default.
• W2065713235 hasConcept C203014093 @default.
• W2065713235 hasConcept C2776914184 @default.
• W2065713235 hasConcept C2776938444 @default.
• W2065713235 hasConcept C2779179475 @default.
• W2065713235 hasConcept C502942594 @default.
• W2065713235 hasConcept C54355233 @default.
• W2065713235 hasConcept C552990157 @default.
• W2065713235 hasConcept C55493867 @default.
• W2065713235 hasConcept C86339819 @default.

• next